Cholangiocarcinoma Market revenue to hit USD 1.3 Billion by 2036, says Research Nester
December 07, 2023 06:30 ET
|
Research Nester
New York , Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global cholangiocarcinoma market size is projected to grow at a CAGR of over 4% from 2024 to 2036. The market is expected to garner a revenue of USD...
Intrahepatic Cholangiocarcinoma Clinical Trial Pipeline Shows Rapid Progress with 20+ Companies Working to Develop Therapies, Assesses DelveInsight
April 06, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 06, 2022 (GLOBE NEWSWIRE) -- Intrahepatic Cholangiocarcinoma Clinical Trial Pipeline Shows Rapid Progress with 20+ Companies Working to Develop Therapies, Assesses DelveInsight ...
Cholangiocarcinoma Pipeline Insight: Therapeutic analysis of 70+ pipeline therapies and 70+ pharmaceutical companies
March 16, 2021 21:20 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, March 16, 2021 (GLOBE NEWSWIRE) -- Cholangiocarcinoma Pipeline Insight: Therapeutic analysis of 70+ pipeline therapies and 70+ pharmaceutical companies Cholangiocarcinoma...